Ambu Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Ambu ha aumentado sus beneficios a una tasa media anual de 23.7%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 6.4% anual. Los ingresos han ido creciendo a una tasa media de 10.1% al año. La rentabilidad financiera de Ambu es de 7.8%, y sus márgenes netos son de 7.8%.
Información clave
23.70%
Tasa de crecimiento de los beneficios
22.01%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | -1.73% |
| Tasa de crecimiento de los ingresos | 10.15% |
| Rentabilidad financiera | 7.82% |
| Margen neto | 7.81% |
| Próxima actualización de resultados | 26 Aug 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • May 19
AMBU B: Lower P/E Expectations Will Support Future Upside Repricing
Analysts have trimmed their price target on Ambu from DKK 110.34 to DKK 88.80, reflecting a more cautious stance following a downgrade in recent research. The revised target still assumes steady revenue growth and a lower future P/E multiple.Artículo de análisis • May 09
Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...
Actualización de narrativa • May 04
AMBU B: Higher Growth And Margins Are Expected To Support Future Upside
Analysts have reduced their price target on Ambu by DKK 12. This reflects updated views on discount rates, expected revenue growth, profit margins and future P/E assumptions.Actualización de narrativa • Apr 20
AMBU B: Reset P/E Assumptions Will Support Future Upside Repricing
Ambu's analyst price target has been reduced by DKK 12 to reflect updated views on its P/E assumptions, revenue growth profile and profitability, with analysts pointing to the recent DKK 12 target cut cited in Street research. Analyst Commentary JPMorgan's DKK 12 reduction in its Ambu price target reflects a reset of P/E expectations and a more cautious stance on the company's revenue growth and profitability profile.Actualización de narrativa • Apr 06
AMBU B: Refined Discount Rate And P/E Expectations Will Support Future Upside
Analysts have lowered their price target on Ambu by DKK 12. This reflects small adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions following recent research updates.Actualización de narrativa • Mar 22
AMBU B: Lower P/E Assumptions Will Support Upside If Execution Improves
Analysts have lowered their price target on Ambu by DKK 12 to reflect slightly adjusted assumptions on fair value, discount rate, revenue growth, profit margin, and future P/E following the recent JPMorgan target cut to DKK 12. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as a reset that could leave room for upside if Ambu delivers on its operational targets.Actualización de narrativa • Mar 08
AMBU B: Share Repurchase Mandate And Lowered Fair Value Will Support Upside
Analysts have trimmed their price target on Ambu by DKK 12 to reflect updated assumptions on fair value, discount rates and earnings expectations following recent research commentary. Analyst Commentary Bullish Takeaways Bullish analysts view the revised DKK 12 lower price target as still consistent with a supportive fair value range.Actualización de narrativa • Feb 22
AMBU B: Share Buybacks And Margin Discipline Will Support Future Upside
The analyst price target for Ambu has been trimmed by DKK 1 to DKK 138, as analysts factor in slightly more cautious assumptions on growth, margins and discount rates following recent price target adjustments, such as the DKK 12 cut highlighted by JPMorgan. Analyst Commentary Bullish analysts remain focused on how Ambu can justify its current valuation through consistent execution on its growth plans, even as some price targets, including the DKK 12 adjustment flagged by JPMorgan, are recalibrated.
Actualización de narrativa • Feb 08
AMBU B: Higher Risk Premium And Margin Pressure Will Reshape Share Outlook
The analyst price target for Ambu has been reduced from DKK 94.54 to DKK 78.00. This change reflects analysts’ updated assumptions on discount rate, revenue growth, profit margin and future P/E, as highlighted by recent Street research including a DKK 12 target cut.Artículo de análisis • Feb 08
Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...Actualización de narrativa • Jan 25
AMBU B: Share Repurchases And Dividend Policy Will Support Future Upside
Analysts have slightly reduced their price target on Ambu, citing modest revisions to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these changes support a more cautious yet still constructive view on the shares.Actualización de narrativa • Jan 11
AMBU B: Share Buybacks And Dividend Policy Will Support Future Upside
Analysts now set Ambu's price target at €139, down from €147, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E that adjust their valuation framework. What's in the News Ambu A/S is set to be removed from the OMX Copenhagen 20 Index, which may affect how some index and benchmark focused investors view or hold the stock (Key Developments).Artículo de análisis • Jan 03
Ambu A/S' (CPH:AMBU B) Price In Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 37.7x Ambu A/S ( CPH:AMBU B ) may be sending very bearish signals at the...Actualización de narrativa • Dec 19
AMBU B: Dividend And Share Buybacks Will Drive Future Upside Potential
Analysts have trimmed their price target for Ambu slightly, lowering fair value by about 1 dollar per share as modestly slower expected revenue growth and profit margins are only partly offset by a slightly higher future P/E multiple and lower discount rate. What's in the News Ambu has launched a new share repurchase program starting December 10, 2025, allowing buybacks of up to 10% of its share capital under a mandate valid until December 13, 2027 (company announcement) The company announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with an ex date of December 4 and record date of December 5, 2025 (company announcement) For fiscal 2025/26, Ambu issued guidance for 10% to 13% organic growth and an EBIT margin of 12% to 14%, or 14% to 16% excluding roughly 2 percentage points of tariff impacts (company guidance) Ambu reaffirmed its 2024/25 financial guidance, maintaining expectations for 12% to 14% organic revenue growth (company guidance) Valuation Changes Fair Value Estimate edged down slightly from DKK 115.59 to DKK 114.79 per share, reflecting a modestly lower fundamental valuation.Artículo de análisis • Dec 12
An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Ambu fair value estimate is kr.130 Ambu's kr.85.60 share price...Actualización de narrativa • Dec 05
AMBU B: Dividend Initiation And Margin Outlook Will Support Future Upside
Analysts have modestly raised their price target on Ambu by DKK 0.00 to reflect a slightly higher discount rate and updated profitability assumptions, while maintaining largely unchanged views on long term growth and valuation multiples. What's in the News Ambu A/S announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with ex-date December 4 and record date December 5, 2025 (Key Developments).Artículo de análisis • Nov 27
We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now
Key Insights Ambu's Annual General Meeting to take place on 3rd of December Salary of kr.8.01m is part of CEO Britt...Actualización de narrativa • Nov 21
AMBU B: Improved Margins And Dividend Outlook Will Support Bullish Momentum
Analysts have slightly lowered their fair value price target for Ambu from DKK 121.41 to DKK 115.59, citing modest decreases in projected revenue growth and profit margin expectations. What's in the News Ambu A/S announced an annual dividend of DKK 0.4100 per share.Actualización de narrativa • Nov 06
AMBU B: Higher Profit Margins Will Drive Hospital Efficiency Improvements
Analysts have revised their fair value estimate for Ambu down from DKK 130.70 to DKK 121.41. They cite a slightly higher discount rate, even though profit margin and revenue growth projections have improved.Artículo de análisis • Oct 07
Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Artículo de análisis • Aug 27
Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.4% to close at kr.98.20 following the...Artículo de análisis • Aug 11
Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?
CPSE:AMBU B 1 Year Share Price vs Fair Value Explore Ambu's Fair Values from the Community and select yours Key...Artículo de análisis • Jul 12
Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?
Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it saw significant share price movement during...Artículo de análisis • May 15
Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye
The stock was sluggish on the back of Ambu A/S' ( CPH:AMBU B ) recent earnings report. We have done some analysis, and...Artículo de análisis • Mar 14
Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Artículo de análisis • Feb 02
Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts
Ambu A/S ( CPH:AMBU B ) last week reported its latest quarterly results, which makes it a good time for investors to...Artículo de análisis • Jan 27
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Artículo de análisis • Jan 12
Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%
Ambu A/S ( CPH:AMBU B ) shareholders would be excited to see that the share price has had a great month, posting a 27...Artículo de análisis • Dec 31
Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?
Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it received a lot of attention from a substantial...
Nueva narrativa • Dec 16
Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth
Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.Artículo de análisis • Nov 28
Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year
Key Insights Ambu will host its Annual General Meeting on 4th of December CEO Britt Jensen's total compensation...Artículo de análisis • Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality
Ambu A/S ( CPH:AMBU B ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that...Artículo de análisis • Nov 07
Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts
Shareholders might have noticed that Ambu A/S ( CPH:AMBU B ) filed its full-year result this time last week. The early...Artículo de análisis • Sep 02
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
It's been a sad week for Ambu A/S ( CPH:AMBU B ), who've watched their investment drop 10% to kr.128 in the week since...Artículo de análisis • Aug 06
Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...Artículo de análisis • Apr 06
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
With a median price-to-sales (or "P/S") ratio of close to 6.1x in the Medical Equipment industry in Denmark, you could...Artículo de análisis • Mar 14
Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...Artículo de análisis • Feb 01
Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 2.9% to close at kr.115 following the release...Artículo de análisis • Jan 02
A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price
It's not a stretch to say that Ambu A/S' ( CPH:AMBU B ) price-to-sales (or "P/S") ratio of 5.9x right now seems quite...Artículo de análisis • Oct 31
Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?
Key Insights Ambu's estimated fair value is kr.114 based on 2 Stage Free Cash Flow to Equity Ambu's kr.66.00 share...Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Ambu. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 6,104 | 477 | 2,642 | 365 |
| 31 Dec 25 | 6,085 | 544 | 2,588 | 362 |
| 30 Sep 25 | 6,037 | 609 | 2,502 | 347 |
| 30 Jun 25 | 5,958 | 359 | 2,447 | 340 |
| 31 Mar 25 | 5,834 | 370 | 2,387 | 337 |
| 31 Dec 24 | 5,647 | 326 | 2,295 | 330 |
| 30 Sep 24 | 5,391 | 235 | 2,231 | 325 |
| 30 Jun 24 | 5,263 | 450 | 2,183 | 321 |
| 31 Mar 24 | 5,075 | 367 | 2,119 | 312 |
| 31 Dec 23 | 4,897 | 238 | 2,130 | 300 |
| 30 Sep 23 | 4,775 | 168 | 2,116 | 295 |
| 30 Jun 23 | 4,679 | -42 | 2,151 | 293 |
| 31 Mar 23 | 4,612 | -65 | 2,160 | 290 |
| 31 Dec 22 | 4,545 | 95 | 2,146 | 286 |
| 30 Sep 22 | 4,444 | 93 | 2,151 | 281 |
| 30 Jun 22 | 4,307 | 222 | 2,113 | 274 |
| 31 Mar 22 | 4,152 | 256 | 2,065 | 255 |
| 31 Dec 21 | 4,031 | 176 | 2,001 | 242 |
| 30 Sep 21 | 4,013 | 247 | 1,938 | 225 |
| 30 Jun 21 | 3,858 | 251 | 1,861 | 210 |
| 31 Mar 21 | 3,832 | 281 | 1,810 | 198 |
| 31 Dec 20 | 3,820 | 290 | 1,760 | 174 |
| 30 Sep 20 | 3,567 | 241 | 1,627 | 157 |
| 30 Jun 20 | 3,302 | 146 | 1,462 | 126 |
| 31 Mar 20 | 3,128 | 270 | 1,301 | 111 |
| 31 Dec 19 | 2,924 | 296 | 1,134 | 106 |
| 30 Sep 19 | 2,820 | 317 | 1,054 | 103 |
| 30 Jun 19 | 2,943 | 515 | 1,000 | 103 |
| 31 Mar 19 | 2,843 | 411 | 962 | 111 |
| 31 Dec 18 | 2,709 | 372 | 920 | 114 |
| 30 Sep 18 | 2,606 | 337 | 872 | 111 |
| 30 Jun 18 | 2,506 | 318 | 848 | 104 |
| 31 Mar 18 | 2,434 | 288 | 824 | 90 |
| 31 Dec 17 | 2,396 | 281 | 804 | 82 |
| 30 Sep 17 | 2,355 | 301 | 790 | 76 |
| 30 Jun 17 | 2,299 | 306 | 747 | 71 |
| 31 Mar 17 | 2,215 | 299 | 726 | 69 |
| 31 Dec 16 | 2,134 | 267 | 711 | 68 |
| 30 Sep 16 | 2,084 | 250 | 700 | 66 |
| 30 Jun 16 | 2,047 | 224 | 715 | 65 |
| 31 Mar 16 | 2,012 | 169 | 700 | 61 |
| 31 Dec 15 | 1,963 | 175 | 692 | 58 |
| 30 Sep 15 | 1,889 | 152 | 665 | 55 |
| 30 Jun 15 | 1,795 | 171 | 616 | 53 |
Ingresos de calidad: AMBU B tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (7.8%) de AMBU B son superiores a los del año pasado (6.3%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de lAMBU B han crecido significativamente en un 23.7% al año.
Acelerando crecimiento: El crecimiento de los beneficios de AMBU B en el último año (28.9%) supera su media de 5 años (23.7% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de AMBU B en el último año (28.9%) superó al de la industria Medical Equipment 2.5%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de AMBU B (7.8%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/22 21:27 |
| Precio de las acciones al final del día | 2026/05/22 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/09/30 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Ambu A/S está cubierta por 14 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| null null | ABG Sundal Collier |
| Michael Healy | Berenberg |
| Susannah Ludwig | Bernstein |